You're signed outSign in or to get full access.
Merck & Co. Inc.
Merck & Co., Inc. is a global healthcare company headquartered in Rahway, New Jersey. Founded over 130 years ago, the company operates as a research-intensive biopharmaceutical corporation, delivering innovative health solutions through prescription medicines, vaccines, biologic therapies, and animal health products. With approximately 75,000 employees as of December 31, 2024, Merck serves patients, healthcare providers, governments, and institutions worldwide. The company is known for its commitment to leading-edge science, a diverse workforce, and its presence in pharmaceuticals, vaccines, and animal health, striving to improve lives globally.
Investment Strategy
Merck & Co., Inc. focuses on advancing scientific innovation to develop prescription medicines, vaccines, biologic therapies, and animal health products. The company prioritizes robust R&D investment (over $17.9 billion in 2024) and maintains a diverse pipeline spanning every development phase. Merck targets therapeutic areas with significant unmet medical needs, leveraging its internal capabilities and external collaborations to deliver solutions that improve and save lives. The company also emphasizes responsible, sustainable business practices, with a mission to be the premier research-intensive biopharmaceutical firm globally.
Latest 13F Filing Activity
Merck & Co. Inc. filed their most recent 13F report on Jun 30, 2025 disclosing 10 equity positions with a total 13F market value of $216M. The fund increased holdings in Personalis Inc., Kymera Therapeutics Inc., Alector Inc. among other positions. Merck & Co. Inc. reduced exposure to Moderna Inc., Xilio Therapeutics Inc., Tuhura Biosciences among others.
Top Holdings
Equity Positions (10)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
P PSNL | PERSONALIS INC | 42.73% | $92.1M | 14,044,943 | $5.78 | $6.56 | +$42.8M |
M MRNA | MODERNA INC | 29.54% | $63.7M | 2,308,190 | $41.58 | $27.59 | -$1.8M |
K KYMR | KYMERA THERAPEUTICS INC | 15.63% | $33.7M | 772,165 | $40.23 | $43.64 | +$12.6M |
A ALEC | ALECTOR INC | 2.30% | $5.0M | 3,545,719 | $1.89 | $1.40 | +$602.8K |
S STRO | SUTRO BIOPHARMA INC | 0.90% | $1.9M | 2,723,509 | $1.84 | $0.71 | +$172.4K |
Industry Allocation
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more